BioSavita, Inc., a biotechnology company, develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (Saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company employs Saccharomyces cerevisiae yeast, which is used in manufacturing various food, beverage, and multiple FDA approved therapeutic products. It develops Twin Cassette yeast expression system for biopharma and biotechnology companies to accelerate the process of bringing the new therapies to market; and throughput synthetic DNA technology platform that enables the manufacture of functional antibodies in secreted form. BioSavita, Inc. was formerly known as ApoLife, Inc.
